bioRxivNeurosciencePreprint
Phosphoproteome modifications and cortical circuit dysfunction are linked to the early-stage progression of alpha-synuclein aggregation.
Sayan DuttaiD, Jennifer A. Hensel, Alicia N. Scott, Rodrigo MohallemiD, Leigh-Ana M. RossittoiD, Hammad F. Khan, Luke A Diehl, Teshawn Johnson, Bryce David Colon, Jacob E. Gold, C G FerreiraiD, Jackeline F MarmolejoiD, Xu CheniD, Krishna JayantiD, Uma K. AryaliD, Laura A. Volpicelli‐DaleyiD, Chris Rochet
Abstract
Cortical dysfunction is increasingly recognized as a major contributor to the non-motor symptoms associated with Parkinsons disease (PD) and other synucleinopathies. Although functional alterations in cortical circuits have been observed in preclinical PD models, the underlying molecular mechanisms are unclear. To bridge this knowledge gap, we investigated tissue-level changes in the cortex of rats and mice treated with alpha-synuclein (aSyn) seeds using a multi-omics approach. Our study revealed significant phosphoproteomic changes, but not global proteomic or lipid profiling changes, in the rat sensorimotor cortex 3 months after intra-striatal injection with aSyn preformed fibrils (PFFs). Gene ontology analysis of the phosphoproteomic data revealed that PFF administration impacted pathways related to synaptic transmission and cytoskeletal organization. Similar phosphoproteomic perturbations were observed in the sensorimotor cortex of mice injected intrastriatally or intracortically with aSyn PFFs. Functional analyses demonstrated increased neuronal firing rates and enhanced spike-spike coherence in the sensorimotor cortex of PFF-treated mice, suggesting that aSyn seeds induced cortical circuit dysfunction. Bioinformatics analysis of the altered phosphosites indicated the involvement of several kinases, including casein kinase-2 (CK2) and Protein Kinase A (PKA). Enrichment of kinase-activating pT/pY MAPK (ERK) phosphosites revealed apparent engagement of the ERK signaling cascade and led to the identification of pERK1/2-positive intraneuronal granulovacuolar body (GVB)-like structures specifically in aggregate-bearing neurons. Collectively, these findings highlight the importance of phosphorylation-mediated signaling pathways in the cortical response to aSyn pathology spread in PD and related synucleinopathies, setting the stage for developing new therapeutic strategies.
- organism: rat
- organism: mouse
- assay: proteomics
- research focus: gene regulatory network inference
- research focus: differential expression
- approach: statistical model
- approach: experimental assay
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cortical synaptic vulnerabilities revealed in a α-synuclein aggregation model of Parkinson's disease
Saroj Kumar Sah, Andrew D. Sauerbeck, … Thomas Biederer·bioRxiv·Jun 20, 2024
- Striatal seeding of protofibrillar alpha-synuclein causes cortical hyperreactivity in behaving mice
Sonja Blumenstock, Fanfan Sun, … Jochen Wolfgang Herms·bioRxiv·Sep 28, 2020
- Cortico-amygdala synaptic structural abnormalities produced by templated aggregation of α-synuclein
Nolwazi Z. Gcwensa, Drèson L. Russell, … Laura A. Volpicelli‐Daley·Neurobiology of DiseasePeer-reviewed·Jul 5, 2024
- Aggregated α-synuclein leads to corticostriatal synaptic dysfunction
Charlotte F. Brzozowski, Harshita Challa, … Mark S. Moehle·bioRxiv·Jan 29, 2025
- Motor Cortical Neuronal Hyperexcitability Associated with α-Synuclein Aggregation
Liqiang Chen, Hiba Douja Chehade, Hong‐Yuan Chu·npj Parkinson s DiseasePeer-reviewed·Jan 14, 2025
- Alpha-synuclein pre-formed fibrils injected into prefrontal cortex primarily spread to cortical and subcortical structures and lead to isolated behavioral symptoms
M. A. Weber, G. Kerr, … G. M. Aldridge·bioRxiv·Jan 31, 2023